Industry News
New treatment regimen may prevent fatal leukemia progression
Oct 09, 2013
Two gene alterations pair up to promote the growth of leukemia cells and their escape from anti-cancer drugs, according to a study in The Journal of Experimental Medicine. Chronic myeloid leukemia (CML) is an aggressive cancer of the blood that is often treated with a drug called Imatinib (a.k.a. Gleevec)... Read More
New decision-making model helps women with early-stage breast cancer decide on most appropriate treatment
Oct 09, 2013
Women with early-stage breast cancer in one breast are increasingly opting to undergo a more aggressive operation to remove both breasts called contralateral prophylactic mastectomy (CPM)... Read More
Detecting BRCA1 and BRCA2 mutations via new, clinically validated diagnostic test
Oct 09, 2013
The recognition of a causal link between mutations in BRCA1 and BRCA2 genes and increased risk of developing breast and ovarian cancer has intensified the demand for genetic testing. Identifying mutations in these large genes by conventional methods can be time consuming and costly... Read More
New treatment regimen may prevent fatal leukemia progression
Oct 09, 2013
Two gene alterations pair up to promote the growth of leukemia cells and their escape from anti-cancer drugs, according to a study in The Journal of Experimental Medicine. Chronic myeloid leukemia (CML) is an aggressive cancer of the blood that is often treated with a drug called Imatinib (a.k.a. Gleevec)... Read More
Improving nutritional status before bladder cancer surgery improves outcomes
Oct 09, 2013
Patients with bladder cancer are two times more likely to have complications after a radical cystectomy procedure if they have a biomarker for poor nutritional status before the operation, according to study findings presented at the 2013 Clinical Congress of the American College of Surgeons... Read More
The human body favors nanodiscs over nanorods
Oct 09, 2013
For years scientists have been working to fundamentally understand how nanoparticles move throughout the human body. One big unanswered question is how the shape of nanoparticles affects their entry into cells. Now researchers have discovered that under typical culture conditions, mammalian cells prefer disc-shaped nanoparticles over those shaped like rods... Read More
Pancreatic cancer: chemo drug Gemzar improves survival rates
Oct 09, 2013
People who have had surgery to remove pancreatic cancer may benefit from better survival time, without the disease progressing, if they are treated with the drug gemcitabine for 6 months after surgery, a study has shown... Read More
New decision-making model helps women with early-stage breast cancer decide on most appropriate treatment
Oct 09, 2013
Women with early-stage breast cancer in one breast are increasingly opting to undergo a more aggressive operation to remove both breasts called contralateral prophylactic mastectomy (CPM)... Read More
Despite evidence suggesting comparable pain relief at lower cost, treatment regimen for bone metastases not widely used
Oct 08, 2013
Justin E. Bekelman, M.D... Read More
Nipple injections to treat breast cancer
Oct 08, 2013
Doctors in Boston, MA, are investigating the possibility of administering drugs directly into the milk ducts via the nipple to treat breast cancer. According to the American Cancer Society, breast cancer is the second most common cancer among American women after skin cancers. They estimate that 1 in 8 women will develop invasive breast cancer during their lifetimes... Read More
Previous Page Next Page